Switch theme
Sign up to access all valuation multiples
Fevertree Drinks PLC is a UK based holding and investment company. The company is engaged in the business activity of developing and marketing premium mixer drinks. Its product portfolio includes Indian tonic water, Mediterranean tonic water, Elderflower tonic water, Aromatic tonic water, Clementine tonic water, Lemon tonic water, Ginger beer, Ginger ale, Smoky ginger ale, Spiced orange ginger ale, Madagascan cola, Sicilian lemonade, Lemonade, Premium Soda Water and Mediterranean Orange. The company operates in the UK, USA, Europe, and other countries, of which majority of the revenue is from the United Kingdom.
2013
380
LTM Revenue $499M
LTM EBITDA $64.6M
$1.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Fever-Tree has a last 12-month revenue (LTM) of $499M and a last 12-month EBITDA of $64.6M.
In the most recent fiscal year, Fever-Tree achieved revenue of $495M and an EBITDA of $61.4M.
Fever-Tree expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Fever-Tree valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $499M | XXX | $495M | XXX | XXX | XXX |
| Gross Profit | $242M | XXX | $186M | XXX | XXX | XXX |
| Gross Margin | 48% | XXX | 38% | XXX | XXX | XXX |
| EBITDA | $64.6M | XXX | $61.4M | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 12% | XXX | XXX | XXX |
| EBIT | $47.3M | XXX | $44.0M | XXX | XXX | XXX |
| EBIT Margin | 9% | XXX | 9% | XXX | XXX | XXX |
| Net Profit | $40.8M | XXX | $32.8M | XXX | XXX | XXX |
| Net Margin | 8% | XXX | 7% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Fever-Tree's stock price is GBP 9 (or $12).
Fever-Tree has current market cap of GBP 1.1B (or $1.4B), and EV of GBP 984M (or $1.3B).
See Fever-Tree trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.3B | $1.4B | XXX | XXX | XXX | XXX | $0.35 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Fever-Tree has market cap of $1.4B and EV of $1.3B.
Fever-Tree's trades at 2.7x EV/Revenue multiple, and 21.5x EV/EBITDA.
Equity research analysts estimate Fever-Tree's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Fever-Tree has a P/E ratio of 35.2x.
See valuation multiples for Fever-Tree and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV (current) | $1.3B | XXX | $1.3B | XXX | XXX | XXX |
| EV/Revenue | 2.7x | XXX | 2.7x | XXX | XXX | XXX |
| EV/EBITDA | 20.4x | XXX | 21.5x | XXX | XXX | XXX |
| EV/EBIT | 27.9x | XXX | 30.0x | XXX | XXX | XXX |
| EV/Gross Profit | 5.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 35.2x | XXX | 43.8x | XXX | XXX | XXX |
| EV/FCF | 18.7x | XXX | 17.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialFever-Tree's last 12 month revenue growth is 5%
Fever-Tree's revenue per employee in the last FY averaged $1.3M, while opex per employee averaged $0.4M for the same period.
Fever-Tree's rule of 40 is 14% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Fever-Tree's rule of X is 26% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Fever-Tree and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 13% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | -2% | XXX | 20% | XXX | XXX | XXX |
| Rule of 40 | 14% | XXX | 18% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 26% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 29% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Agthia Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Acomo | XXX | XXX | XXX | XXX | XXX | XXX |
| ForFarmers | XXX | XXX | XXX | XXX | XXX | XXX |
| JDE Peets | XXX | XXX | XXX | XXX | XXX | XXX |
| Sligro Food Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Fever-Tree acquired XXX companies to date.
Last acquisition by Fever-Tree was XXXXXXXX, XXXXX XXXXX XXXXXX . Fever-Tree acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Fever-Tree founded? | Fever-Tree was founded in 2013. |
| Where is Fever-Tree headquartered? | Fever-Tree is headquartered in United Kingdom of Great Britain and Northern Ireland. |
| How many employees does Fever-Tree have? | As of today, Fever-Tree has 380 employees. |
| Who is the CEO of Fever-Tree? | Fever-Tree's CEO is Mr. Timothy Daniel Gray Warrillow. |
| Is Fever-Tree publicy listed? | Yes, Fever-Tree is a public company listed on LON. |
| What is the stock symbol of Fever-Tree? | Fever-Tree trades under FEVR ticker. |
| When did Fever-Tree go public? | Fever-Tree went public in 2014. |
| Who are competitors of Fever-Tree? | Similar companies to Fever-Tree include e.g. Agthia Group, Acomo, ForFarmers, JDE Peets. |
| What is the current market cap of Fever-Tree? | Fever-Tree's current market cap is $1.4B |
| What is the current revenue of Fever-Tree? | Fever-Tree's last 12 months revenue is $499M. |
| What is the current revenue growth of Fever-Tree? | Fever-Tree revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Fever-Tree? | Current revenue multiple of Fever-Tree is 2.7x. |
| Is Fever-Tree profitable? | Yes, Fever-Tree is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Fever-Tree? | Fever-Tree's last 12 months EBITDA is $64.6M. |
| What is Fever-Tree's EBITDA margin? | Fever-Tree's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Fever-Tree? | Current EBITDA multiple of Fever-Tree is 20.4x. |
| What is the current FCF of Fever-Tree? | Fever-Tree's last 12 months FCF is $70.7M. |
| What is Fever-Tree's FCF margin? | Fever-Tree's last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Fever-Tree? | Current FCF multiple of Fever-Tree is 18.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
